A study assessing IOP fluctuations of K-115 in combination with latanoprost
Phase 3
- Conditions
- POAG or OH
- Registration Number
- JPRN-jRCT2080222237
- Lead Sponsor
- Kowa Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
1. Patients with POAG or OH
2. IOP after a run-in period with latanoprost>=18mmHg
Exclusion Criteria
1.Patients with decreased visual performance
2.Patients thought to use glaucoma medication during this trial
3.Patients thought to wear contact lenses during this trial
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method